Syndax Pharmaceuticals Inc (SNDX)
NASDAQ:SNDX
Holding SNDX?
Track your performance easily

Syndax Pharmaceuticals (SNDX) Ownership - Who Owns Syndax Pharmaceuticals?

597 Followers

Syndax Pharmaceuticals (SNDX) Ownership Overview

5.98%19.00%0.96%13.55%60.51%
0.96% Other Institutional Investors
13.55% ETFs
60.51% Public Companies and
Individual Investors
The ownership structure of Syndax Pharmaceuticals (SNDX) stock is a mix of institutional, retail, and individual investors. Approximately 33.50% of the company’s stock is owned by Institutional Investors, 5.98% is owned by Insiders, and 60.51% is owned by Public Companies and Individual Investors.
The ownership structure of {name} ({ticker}) stock is a mix of institutional, retail, and individual investors. {displayInstitutionalData, select, display {Approximately {institutionalPercentage} of the company’s stock is owned by Institutional Investors} other {}}{displayInsiderText, select, display {, {insidersPercentage} is owned by Insiders} other {}}{displayInvestorsText, select, display {, and {retailInvestorsPercentage} is owned by Public Companies and Individual Investors.} other {}}

Recent Insider Trading Activity

Date
Name
Activity
Value
Jun 17, 2024
xxxxxxxxxxxxx
$25025

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Jun 30, 2024
xxxxxxxxxxxxx
$22377
Jun 30, 2024
xxxxxxxxxxxxx
$1553115
Jun 30, 2024
xxxxxxxxxxxxx
$31729689

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
4,568,823Institution5.37%85,665,431
3,520,402Insider5.10%66,007,538
4,249,352Institution4.99%79,675,350
3,821,997Institution4.49%71,662,444
3,815,750Institution4.48%71,545,313
1,938,939Institution2.28%36,355,106
1,545,528Institution1.82%28,978,650
1,025,000Institution1.20%19,218,750
993,413Institution1.17%18,626,494
973,057Institution1.14%18,244,819

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
4,249,352Institution4.99%79,675,350
3,821,997Institution4.49%71,662,444
993,413Institution1.17%18,626,494
922,142Institution1.08%17,290,163
893,651Institution1.05%16,755,956
829,648Institution0.97%15,555,900
650,000Institution0.76%12,187,500
460,028Institution0.54%8,625,525
373,047Institution0.44%6,994,631
370,003Institution0.43%6,937,556

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
2,597,085Institution3.05%49,993,886
2,141,357Institution2.52%40,150,444
1,825,658Institution2.15%34,669,245
1,256,086Institution1.48%24,179,656
730,117Institution0.86%13,689,694
559,920Institution0.66%10,498,500
411,223Institution0.48%7,809,125
376,990Institution0.44%7,257,058
254,334Institution0.30%4,895,930
103,108Institution0.12%1,933,275

FAQ

Who Owns Syndax Pharmaceuticals Inc (SNDX)?
According to the latest TipRanks data, approximately 0.96% of the company's stock is held by institutional investors, 5.98% is held by insiders, and 60.51% is held by retail investors.
    What percentage of Syndax Pharmaceuticals Inc (SNDX) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 0.96% of Syndax Pharmaceuticals Inc (SNDX) stock is held by institutional investors.
      What percentage of Syndax Pharmaceuticals Inc (SNDX) stock is held by retail investors?
      According to the latest TipRanks data, approximately 60.51% of Syndax Pharmaceuticals Inc (SNDX) stock is held by retail investors.
        Who owns the most shares of Syndax Pharmaceuticals Inc (SNDX)?
        Vanguard owns the most shares of Syndax Pharmaceuticals Inc (SNDX).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis